Flagellation in Crohn disease

The intestinal mucosa is challenged with more bacterial antigens than any other tissue in the body. Previous work has indicated that inflammatory bowel disease (IBD) results from maladaptive immune responses to intestinal microbiota. However, identification of microbial antigens underlying such intestinal disorders remains difficult due to the diversity of microflora present in these tissues. Through serological cloning of antigens, Robert Hershberg and colleagues, from the Dendreon Corporation, determined that the dominant antigens that instigate pathogenesis in Crohn disease (CD) are from a family of related novel flagellins, the major protein components of bacterial flagella. They examined sera from colitic C3H/HeJBir mice and found reactivity to 15 flagellin clones. Using recombinant flagellin fragments and ELISA assays, they showed that the amino terminus was the immunoreactive domain. Serological studies confirmed that sera from CD patients had high reactivity against particular flagellins, whereas sera from controls and from patients suffering from another IBD, ulcerative colitis, were nonreactive. These findings underscore the link between the innate immune response and the pathogenesis of IBD and offer leads to the identification of other causal antigens in CD.


Contact: Laurie Goodman
Journal of Clinical Investigation

Page: 1

Related biology news :

1. IBD (Crohns, Colitis) joins cancer, inflammatory diseases in associated blood vessel growth
2. IBD (Crohns/ulcerative colitis) conference adds 18 speakers; APS meeting starts Thursday
3. Research gives hope to preemies and Crohns patients
4. U of T researchers isolate gene for Crohns disease
5. Researchers find first gene that increases risk of Crohns disease
6. Researchers identify 170 genes involved in Crohns disease and ulcerative colitis
7. New Gene Holds Promise For Controlling Crohns And Other Inflammatory Diseases
8. NIEHS Finds Protein That Counteracts Inflammation And Wasting That May Target Rheumatoid Arthritis And Crohns Disease
9. New Evidence For Growth Factor Role In Crohns Disease
10. The Many Faces Of Malnutrition In Crohn Disease
11. Comprehensive Nutritional Status In Patients With Long-Standing Crohn Disease Currently In Remission

Post Your Comments:

(Date:1/20/2019)... (PRWEB) , ... January 16, 2019 , ... ... collaboration with doc.ai, a medical research platform that uses artificial intelligence (AI) and ... effective supplements for Crohn’s disease and ulcerative colitis. , People will Crohn’s or ...
(Date:1/20/2019)... , ... January 17, 2019 , ... ... to drug metabolism and distribution has been documented for many years. These observed ... in terms of adverse event profiles in patients residing in different geographic regions. ...
(Date:1/14/2019)... ... January 14, 2019 , ... CellMax Life , a ... blood, will present new findings at the ASCO Gastrointestinal Cancer Symposium in San ... results from this study show CellMax Life’s blood test, based on its proprietary ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... January 29, 2019 , ... ... announced the dosing of the first patient in a phase 1/2 clinical study ... disease associated with high morbidity and often leads to premature death. There ...
(Date:1/30/2019)... ... January 30, 2019 , ... In 2016, Veronafiere ... to promote and give recognition to producers whose work focuses entirely on natural, ... place in Verona, Italy, contemporaneously to the 5StarWines blind tasting organized from April ...
(Date:1/24/2019)... (PRWEB) , ... January 23, 2019 , ... ... in microbial genomics, has awarded microbiome research support in study design, planning, sample ... Faculty of Medical Sciences, St. Augustine Campus in Trinidad led by Dr. Elaine ...
(Date:1/20/2019)... , ... January 17, 2019 , ... ... Platinum Partner announces the launch of a specialized automation technology, titled Automate 3D. ... for automatic generation of models and drawings to deliver to end-users, customers, and ...
Breaking Biology Technology:
Cached News: